Review
- Page Path
-
- HOME
- ARTICLE CATEGORY
- Review
- Review
- NADPH oxidase mediated oxidative stress in hepatic fibrogenesis
- Yong-Han Paik, David A. Brenner
- Clin Mol Hepatol. 2011;17(4):251-257. Published online December 26, 2011
-
View: 9889 Download: 78 Crossref: 40
- The diagnosis and treatment of primary biliary cirrhosis
- Kyung-Ah Kim, Sook-Hyang Jeong
- Clin Mol Hepatol. 2011;17(3):173-179. Published online September 30, 2011
-
View: 9231 Download: 92 Crossref: 13
- Epidemiology and prevention of hepatitis B virus infection
- So Young Kwon, Chang Hong Lee
- Clin Mol Hepatol. 2011;17(2):87-95. Published online June 23, 2011
-
View: 14035 Download: 157 Crossref: 83
- Chronic hepatitis B in pregnancy: unique challenges and opportunities
- Kumaresan Yogeswaran, Scott K. Fung
- Clin Mol Hepatol. 2011;17(1):1-8. Published online March 21, 2011
-
View: 8384 Download: 66 Crossref: 16
- Hemodynamic alterations in cirrhosis and portal hypertension
- Moon Young Kim, Soon Koo Baik, Samuel S. Lee
- Clin Mol Hepatol. 2010;16(4):347-352. Published online December 31, 2010
-
View: 11458 Download: 169 Crossref: 69
- New treatments for chronic hepatitis C
- Jae Young Jang, Raymond T. Chung
- Clin Mol Hepatol. 2010;16(3):263-277. Published online September 30, 2010
-
View: 8522 Download: 45 Crossref: 14
- Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease
- Yue Wang, Sherlot Juan Song, Yichong Jiang, Jimmy Che-To Lai, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Terry Cheuk-Fung Yip
- Received April 10, 2024 Accepted June 26, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0246 [Accepted]
-
View: 955 Download: 125 Crossref: 1
- Current status and perspective on molecular targets and therapeutic intervention strategy in hepatic ischemia-reperfusion injury
- Jia Liu, Ranyi Luo, Yinhao Zhang, Xiaojiaoyang Li
- Received April 3, 2024 Accepted June 26, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0222 [Accepted]
-
View: 1037 Download: 170
- Review Article
- Immunological mechanisms in steatotic liver diseases: An overview and clinical perspectives
- Mengyao Yan, Shuli Man, Long Ma, Lanping Guo, Luqi Huang, Wenyuan Gao
- Received April 28, 2024 Accepted July 10, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0315 [Accepted]
-
View: 913 Download: 112
- Review
- Precision medicine and nucleotide-based therapeutics to treat MASH
- Andrea Caddeo, Stefano Romeo
- Received June 8, 2024 Accepted August 4, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0438 [Accepted]
-
View: 837 Download: 166 Crossref: 1
- Review Article
- Criteria and prognostic models for patients with hepatocellular carcinoma undergoing liver transplantation
- Meng Sha, Jun Wang, Jie Cao, Zhi-Hui Zou, Xiao-ye Qu, Zhi-feng Xi, Chuan Shen, Ying Tong, Jian-jun Zhang, Seogsong Jeong, Qiang Xia
- Received April 30, 2024 Accepted August 12, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0323 [Accepted]
-
View: 474 Download: 57
- Epidemiology of Metabolic Dysfunction-Associated Steatotic Liver Disease
- Zobair M. Younossi, Markos Kalligeros, Linda Henry
- Received June 6, 2024 Accepted August 15, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0431 [Accepted]
-
View: 1271 Download: 284 Crossref: 2
- Review
- Roles of X-box binding protein 1 in liver pathogenesis
- Jihoon Tak, Yun Seok Kim, Sang Geon Kim
- Received June 10, 2024 Accepted September 27, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0441 [Accepted]
-
View: 278 Download: 33
- Review Article
- Sinusoidal communication in chronic liver disease
- Albert Gibert-Ramos, María Andrés-Rozas, Raül Pastó, Pablo Alfaro-Retamero, Sergi Guixé-Muntet, Jordi Gracia-Sancho
- Received August 29, 2024 Accepted October 2, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0734 [Accepted]
-
View: 248 Download: 60
-
Clinical and
Molecular
HepatologyPrint ISSN: 2287-2728
Online ISSN: 2287-285X
-
-
- Immunopathogenesis of liver fibrosis in steatotic liver disease
- Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
- Recent updates on pharmacologic therapy in non-alcoholic fatty liver disease
- The role of the hepatic autonomic nervous system
- HBeAg-positive grey-zone patients: Treatment beyond guideline recommendations?
- Systemic therapy in advanced hepatocellular carcinoma
- Epidemiology and updated management for autoimmune liver disease
- Microbiome and metabolomics in alcoholic liver disease
- Personalized medicine in nonalcoholic fatty liver disease
- Acute on chronic liver failure in cirrhosis
- Current status and outcome of liver transplantation in South Korea
- History and future of hepatitis B virus control in South Korea
- Hepatocellular carcinoma statistics in South Korea
Impact Factor14.0First decision
07 Days
Publication after acceptance
03 Days
*Last 12 months
- MOST VIEWED (Last 6 months)
- MOST CITED (2022-2024)
|
|||||||
